1. Home
  2. EVLV vs TVTX Comparison

EVLV vs TVTX Comparison

Compare EVLV & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVLV
  • TVTX
  • Stock Information
  • Founded
  • EVLV 2013
  • TVTX 2008
  • Country
  • EVLV United States
  • TVTX United States
  • Employees
  • EVLV N/A
  • TVTX N/A
  • Industry
  • EVLV Computer peripheral equipment
  • TVTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVLV Technology
  • TVTX Health Care
  • Exchange
  • EVLV Nasdaq
  • TVTX Nasdaq
  • Market Cap
  • EVLV 1.4B
  • TVTX 1.5B
  • IPO Year
  • EVLV N/A
  • TVTX N/A
  • Fundamental
  • Price
  • EVLV $7.46
  • TVTX $24.64
  • Analyst Decision
  • EVLV Strong Buy
  • TVTX Strong Buy
  • Analyst Count
  • EVLV 4
  • TVTX 16
  • Target Price
  • EVLV $8.88
  • TVTX $35.20
  • AVG Volume (30 Days)
  • EVLV 4.3M
  • TVTX 2.7M
  • Earning Date
  • EVLV 08-14-2025
  • TVTX 10-30-2025
  • Dividend Yield
  • EVLV N/A
  • TVTX N/A
  • EPS Growth
  • EVLV N/A
  • TVTX N/A
  • EPS
  • EVLV N/A
  • TVTX N/A
  • Revenue
  • EVLV $121,011,000.00
  • TVTX $333,865,000.00
  • Revenue This Year
  • EVLV $31.07
  • TVTX $83.87
  • Revenue Next Year
  • EVLV $17.67
  • TVTX $40.99
  • P/E Ratio
  • EVLV N/A
  • TVTX N/A
  • Revenue Growth
  • EVLV 36.64
  • TVTX 87.94
  • 52 Week Low
  • EVLV $2.04
  • TVTX $12.91
  • 52 Week High
  • EVLV $8.91
  • TVTX $28.69
  • Technical
  • Relative Strength Index (RSI)
  • EVLV 41.95
  • TVTX 59.38
  • Support Level
  • EVLV $7.63
  • TVTX $23.22
  • Resistance Level
  • EVLV $8.02
  • TVTX $25.10
  • Average True Range (ATR)
  • EVLV 0.40
  • TVTX 1.27
  • MACD
  • EVLV -0.13
  • TVTX -0.23
  • Stochastic Oscillator
  • EVLV 10.71
  • TVTX 63.75

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

Share on Social Networks: